Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Añadir filtros








Intervalo de año
1.
Rev. Soc. Bras. Med. Trop ; 51(1): 44-51, Jan.-Feb. 2018. tab, graf
Artículo en Inglés | LILACS | ID: biblio-897051

RESUMEN

Abstract INTRODUCTION: Multidrug-resistant (MDR) Escherichia coli, a species that is a leading cause of urinary tract infections (UTIs) and is a major global public health concern. This study was designed to detect the differences in antibiotic resistance patterns, the production and type of extended spectrum β-lactamases (ESBLs), and the clonal relationships among E. coli isolates from UTIs and fecal samples. METHODS: Antibacterial resistance was determined by the disk diffusion method. ESBL, carbapenemase, and AmpC-producing isolates were detected phenotypically. Then, the ESBL genes were sequenced to detect the type. Enterobacterial repetitive intergenic consensus-polymerase chain reaction (ERIC-PCR) was performed on the ESBL-positive isolates. RESULTS: The most common effective antibacterial agents were colistin, imipenem, and amikacin. Among the isolates, 204 (56.6%) were MDR. Of the 163 ESBL-positive isolates, 11 (6.7%) produced AmpC, and the frequencies of beta-lactamase-positive genes were as follows: bla CTX-Mgroup1, 76%; bla TEM1, 74.8%; bla SHV12, 1.2%; and bla OXA1, 12.88%. ERIC PCR showed a diverse pattern, suggesting that clonal spread of E. coli in this area is uncommon, and that most of the infecting strains are endogenous. CONCLUSIONS: The high rates of antibacterial-resistant and MDR isolates are quite important since these strains can act as source of resistant bacteria that can be spread in the community. Controlling antibiotic use, against inappropriate use and abuse, in the community and continuous surveillance of emerging resistance traits are critical to controlling the spread of resistance.


Asunto(s)
Humanos , Infecciones Urinarias/microbiología , beta-Lactamasas/genética , Escherichia coli/efectos de los fármacos , Heces/microbiología , Antibacterianos/farmacología , beta-Lactamasas/efectos de los fármacos , Reacción en Cadena de la Polimerasa , Farmacorresistencia Bacteriana Múltiple , Escherichia coli/aislamiento & purificación , Escherichia coli/enzimología , Pruebas Antimicrobianas de Difusión por Disco , Irán
2.
Rev. Soc. Bras. Med. Trop ; 51(1): 88-93, Jan.-Feb. 2018. tab
Artículo en Inglés | LILACS | ID: biblio-1041448

RESUMEN

Abstract INTRODUCTION: Here, we determined the genes encoding antibiotic resistance enzymes and virulence factors and evaluated the genetic relationship between Enterobacter spp. isolated from different clinical samples. METHODS: A total of 57 clinical isolates of Enterobacter spp. were tested for the production of extended-spectrum β-lactamases (ESBLs), carbapenemase, and AmpC using phenotypic and genotypic methods. RESULTS: The most common ESBLs and AmpC β-lactamases were bla TEM (63.3%) and bla EBC (57.7%), respectively. The most prevalent virulence gene was rpos (87.7%). The random amplified polymorphic DNA (RAPD) patterns of strains were genetically unrelated. CONCLUSIONS: RAPD polymerase chain reaction analysis revealed high genetic diversity among isolates.


Asunto(s)
Humanos , Proteínas Bacterianas/biosíntesis , Proteínas Bacterianas/genética , beta-Lactamasas/genética , Escherichia coli/efectos de los fármacos , Heces/microbiología , Antibacterianos/farmacología , Fenotipo , Proteínas Bacterianas/efectos de los fármacos , beta-Lactamasas/biosíntesis , Reacción en Cadena de la Polimerasa , Células Clonales , Farmacorresistencia Bacteriana Múltiple , beta-Lactamas/efectos adversos , Escherichia coli/enzimología , Escherichia coli/genética , Pruebas Antimicrobianas de Difusión por Disco , Genotipo , Irán
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA